meglumine has been researched along with Splenic Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Byun, JH; Kang, BK; Kim, HJ; Kim, JH; Kim, SY; Lee, MG; Lee, SS | 1 |
| Boll, DT; Chea, YW; Dale, BM; Merkle, EM; Neville, AM; Samei, E; Wang, CL | 1 |
| Buffet, PA; Derouin, F; Garin, YJ; Nassar, N; Sulahian, A | 1 |
| Awaya, H; Fujita, T; Honjo, K; Ito, K; Koike, S; Matsumoto, T; Matsunaga, N; Mitchell, DG; Takano, K | 1 |
| Fretzayas, A; Karpathios, T; Kitsiou, S; Mathioudakis, J; Moustaki, M | 1 |
| Greenberg, HM; Kroeker, MA; Lawrence, PH; Madden, TP; Semelka, RC; Shoenut, JP | 1 |
1 trial(s) available for meglumine and Splenic Diseases
| Article | Year |
|---|---|
Spleen: dynamic enhancement patterns on gradient-echo MR images enhanced with gadopentetate dimeglumine.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Prospective Studies; Retrospective Studies; Single-Blind Method; Spleen; Splenic Diseases; Tomography, X-Ray Computed | 1992 |
5 other study(ies) available for meglumine and Splenic Diseases
| Article | Year |
|---|---|
Diffusion-weighted MRI: usefulness for differentiating intrapancreatic accessory spleen and small hypervascular neuroendocrine tumor of the pancreas.
Topics: Adult; Aged; Contrast Media; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Humans; Image Enhancement; Male; Meglumine; Middle Aged; Neuroendocrine Tumors; Observer Variation; Organometallic Compounds; Pancreas; Pancreatic Neoplasms; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Spleen; Splenic Diseases; Young Adult | 2014 |
Effect of gadolinium chelate contrast agents on diffusion weighted MR imaging of the liver, spleen, pancreas and kidney at 3 T.
Topics: Adult; Analysis of Variance; Contrast Media; Diffusion Magnetic Resonance Imaging; Echo-Planar Imaging; Female; Gadolinium DTPA; Humans; Kidney Diseases; Liver Diseases; Male; Meglumine; Middle Aged; Organometallic Compounds; Pancreatic Diseases; Retrospective Studies; Splenic Diseases | 2011 |
Therapeutic effect of reference antileishmanial agents in murine visceral leishmaniasis due to Leishmania infantum.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Female; Leishmania infantum; Leishmaniasis, Visceral; Liver Diseases, Parasitic; Lung Diseases, Parasitic; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Parasitology; Paromomycin; Splenic Diseases | 1996 |
Gadolinium-enhanced MR imaging of the spleen: artifacts and potential pitfalls.
Topics: Aged; Artifacts; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Liver; Liver Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Spleen; Splenic Diseases | 1996 |
Splenic granulomatous lesions in immunocompetent pediatric patients with visceral leishmaniasis.
Topics: Antiprotozoal Agents; Child; Child, Preschool; Granuloma; Humans; Immunocompetence; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prognosis; Splenic Diseases; Treatment Outcome | 2001 |